Helicos Raises Funding
The company will sell 42,753,869 units. Each unit consists of one share of common stock and one warrant to purchase 0.6 shares of common stock at a price of $0.45 per share for a purchase price of $0.435 per unit.
Cambridge, MA 12/19/08—Helicos BioSciences, a developer of DNA sequencing technology, has announced an agreement to raise approximately $18.6 million through a private placement sale of its common stock and warrants. Net proceeds are expected to be $17.9 million. Earlier this month, the company announced cost reduction measures (see IBO 12/15/08). Purchasers include current investors such as Flagship Ventures, Atlas Ventures, Highland Capital and Versant Ventures.
< Previous Article | Next Article >
